CTRI/2014/09/005016招募中未知
A Prospective, Double Blind, Placebo-Controlled, Randomized, Multicentric, study to evaluate the efficacy and safety of PreCrea®, a twice-daily nutritional supplement in people with higher than normal blood sugar levels.
Preemptive Meds Private Limited0 个研究点目标入组 210 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 210
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Age >= 18 years to <= 65 years
- •Newly diagnosed Male or Female participants with higher than normal blood sugar levels i.e. Fasting Plasma Glucose of >100 mg/dl as defined by ADA expert committee on the diagnosis and classification of Pre-Diabetes and Diabetes Mellitus during screening and not on any treatment
- •Participants who are on Metformin 500 mg twice a day (1000 mg per day) treatment with lifestyle modification programme for atleast 03 months and have HbA1c >7.5 %
- •Ability to understand and willingness to sign and date a written Informed Consent Document at the screening visit before any protocol- specific procedures are performed and willing to adhere to the protocol and entire trial procedures
排除标准
- •Subjects with Type 1 Diabetes Mellitus
- •Participants on insulin therapy and other oral anti-diabetic agents or having uncontrolled diabetes.
- •Stroke, myocardial infarction, coronary artery bypass graft (CABG) percutaneous transluminal coronary angioplasty (PTCA) or angina pectoris within the last 12 months.
- •Cardiac status New York Heart Association class III-IV
- •Uncontrolled blood pressure 150 mmhg systolic and 100 mmhg diastolic
- •Impaired renal function as shown by but not limited to serum creatinine >= 1.5 mg/dl for males and >= 1.4 mg/dl for female
- •Clinically significant peripheral edema
- •Clinical evidence of active liver disease or serum alenine aminotransferase (ALT) or aspartate amino transferase (AST) 2.5 times the upper limit of the normal range (2.5 X ULN)
- •Participants on steroid
- •Pregnancy or lactating women
- •Known hypersensitivity to any of the study drugs
- •Any malignancy within the last 5 years, with exception of adequately treated basal or squamous cell carcinoma of the skin or adequately treated carcinoma insitu.
- •Current addiction or current alcohol abuse or history of substance or alcohol abuse within the last 2 years
- •Subject is the investigator or any sub-investigator, research assistant, pharmacist, study coordinator, other staff or relative thereof directly involved in the conduct of the protocol
- •Mental condition rendering the subject unable to understand the nature, scope and possible consequences of the study. Subject unlikely to comply with protocol e.g. uncooperative attitude, inability to return for follow up visits and unlikelihood completing of the study.
- •Any disease or condition that in the opinion of the investigator and/or sponsor may interfere with the completion of the study.
研究者
相似试验
进行中（未招募）
不适用
Study to evaluate Efficacy and Safety of PreLipid® on subjects with higher than normal blood lipid levelsCTRI/2014/10/005077Preemptive Meds Private Limited210
已完成
不适用
Clinical Study on Collagen Peptide of Titan Biotech Limited for Skin, Nail and Hair Health in Adults.CTRI/2019/06/019857Titan Biotech Limited72
已完成
不适用
Clinical Study on Collagen Peptide of Titan Biotech Limited for OsteoArthritis in Adults.CTRI/2019/06/019856Titan Biotech Limited72
进行中（未招募）
不适用
A Prospective, Randomised, Double-blind, Placebo-controlled, Parallel-group, International Multicentre Phase III Trial of PI-88 in the Adjuvant Treatment of Post-resection Hepatocellular Carcinoma (PATHWAY) - PATHWAYpost-resection hepatocellular carcinomaMedDRA version: 6.1Level: PTClassification code 10019701EUCTR2007-005011-25-ITPROGEN PHARMACEUTICALS LIMITED600
进行中（未招募）
1 期
Investigation on the effect and tolerability of erenumab in trigeminal neuralgiaMedDRA version: 20.0Level: PTClassification code 10044652Term: Trigeminal neuralgiaSystem Organ Class: 10029205 - Nervous system disordersTrigeminal neuralgiaEUCTR2019-000848-95-DKDansk Hovedpine Center, Neurologisk Klinik, Rigshospitalet - Glostrup80